Page last updated: 2024-10-26

domperidone and Tardive Dystonia

domperidone has been researched along with Tardive Dystonia in 1 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Research Excerpts

ExcerptRelevanceReference
"Domperidone has difficulty passing the blood-brain barrier, thus rarely causes tardive dyskinesia."7.91Severe tardive dyskinesia induced by domperidone in presenile and non-dementia type 2 diabetes man with alcohol misuse showing albuminocytological dissociation and white matter hyperintensity. ( Kanzaki, A; Nakamura, T; Otsuka, A; Tada, H, 2019)
"Domperidone has difficulty passing the blood-brain barrier, thus rarely causes tardive dyskinesia."3.91Severe tardive dyskinesia induced by domperidone in presenile and non-dementia type 2 diabetes man with alcohol misuse showing albuminocytological dissociation and white matter hyperintensity. ( Kanzaki, A; Nakamura, T; Otsuka, A; Tada, H, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanzaki, A1
Tada, H1
Otsuka, A1
Nakamura, T1

Other Studies

1 other study available for domperidone and Tardive Dystonia

ArticleYear
Severe tardive dyskinesia induced by domperidone in presenile and non-dementia type 2 diabetes man with alcohol misuse showing albuminocytological dissociation and white matter hyperintensity.
    BMJ case reports, 2019, May-29, Volume: 12, Issue:5

    Topics: Alcoholism; Blood-Brain Barrier; Diabetes Mellitus, Type 2; Diagnosis, Differential; Domperidone; Do

2019